Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
30
Number of overlapping holdings
28.8%
% of BBC's 125 holdings also in CNCR
41.7%
% of CNCR's 72 holdings also in BBC
Overlap by Weight
Sector Drift (BBC minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBC |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
MERUS N.V. | 1.1% | 1.8% | 1.1% |
 |
ALLOGENE THERAPEUTICS, INC. | 1.1% | 1.1% | 1.1% |
|
SYNDAX PHARMACEUTICALS INC | 1.0% | 1.5% | 1.0% |
|
SUMMIT THERAPEUTICS INC | 1.0% | 1.4% | 1.0% |
|
REPLIMUNE GROUP, INC. | 0.9% | 2.0% | 0.9% |
Position Highlights (Non-Overlapping Exposures)
BBC Overweight Relative to CNCR
|
AKERO THERAPEUTICS, INC. | 1.5% |
|
LIQUIDIA TECHNOLOGIES, INC. | 1.4% |
|
SANA BIOTECHNOLOGY, INC. | 1.3% |
|
XERIS PHARMACEUTICALS INC | 1.3% |
|
ARCUTIS BIOTHERAPEUTICS INC | 1.2% |
 |
PROTHENA CORP PLC | 1.1% |
|
ANAPTYSBIO, INC. | 1.1% |
|
VERVE THERAPEUTICS, INC. | 1.1% |
|
VIR BIOTECHNOLOGY, INC. | 1.1% |
|
DIANTHUS THERAPEUTICS INC | 1.0% |
BBC Underweight Relative to CNCR
|
INTREXON CORP | -3.2% |
|
EXELIXIS INC | -2.7% |
|
SPRINGWORKS THERAPEUTICS, INC. | -2.7% |
|
RECURSION PHARMACEUTICALS, INC CLASS | -2.6% |
|
GENELUX CORP. | -2.5% |
|
BRISTOL-MYERS SQUIBB CO | -2.4% |
|
COMPASS THERAPEUTICS, INC. | -2.4% |
|
2SEVENTY BIO, INC. | -2.1% |
|
BLUEPRINT MEDICINES CORP. | -2.1% |
|
SCHRODINGER, INC. | -2.0% |